Abstract:Background:The intestine is now known as a key metabolic organ that is involved in the development of metabolic complications in obesity and diabetes.Studies on obese and insulin resistant rodents and humans show that small intestine develops a local insulin resistance state, an altered lipid and lipoprotein metabolism, low-grade inflammation and increased paracellular permeability.Because of the complex microenvironment surrounding intestinal epithelial cells, it is not clear so far whether intestinal dyshomeostasis is primarily induced by exogenous obesity-related factors or is a response to obesity-related endogenous alterations in the host.Objectives: To assess the impact of obesity-related endogenous factors (i.e.hyperglycemia, dyslipidemia, inflammation or endocannabinoid system activation) on intestinal epithelial functions in organoids.Methods: Organoids, derived from male C57BL/ 6 mouse duodenum, were incubated 24h with the following conditions: a) inflammatory state (20 mM LPS, 100 nM TNF a, IL-1b and IFNg); b) dyslipidemia (5 mM vs. 2 mM of Palmitate:Oleate [2:1] in 1 mM BSA); c) hyperglycemia (2600 mg/L vs. 1000 mg/L); and d) endocannabinoid system activators(ACEA and Noladin).Results: Incubation of organoids with insulin (30 min, EC50=10 nM) induced a dose-response activation of Akt Ser473 phosphorylation.Insulin signaling was blunted by the induction of an inflammatory state (-50%, p<0.05) and by free fatty acid levels similar to dyslipidemia (-37%, p<0.05) while hyperglycemia only reduce insulin sensitivity at much higher glucose levels than observed in diseases [>4500 mg/L].These obesity-related endogenous factors also impact the expression of several genes related to the epithelial cell functions in the intestine.The inflammatory state increase expression of genes related to intestinal paracellular permeability ( Tjp, Ocln, Marveld2), immune and inflammatory response (Def20, Muc1, Lyz2, Tnf), lipid and lipoprotein metabolism (Mttp, Dgat1/2, Acss2, Acaca) and nutrient transport (Slc2a2/5, Slc5a1, Abcg5/8, Fabp2).Endocannabinoid system activation also led to several changes in the expression of genes related to intestinal paracellular permeability ( Tjp, Marveld2), immune and inflammatory response (Def20, Lyz2, Muc2, Tnf), lipid and lipoprotein metabolism (Mttp, Dgat1, Fabp2) and glucose homeostasis (Gip, Slc2a2/5, Slc5a1) but with divergent effects according to the ligands (ACEA vs. Noladin).Conclusion: This study demonstrates that basolateral exposure of small intestine epithelium organoids to obesity-related factors impact the ability of the cell to signal insulin and suggest the development of alterations in other key intestinal functions.Overall, this study suggests that the host metabolic states may represent an important mechanism in the development of small intestine alteration in obesity.

MyD88 Expression on Villin Inhibits Obesity in High Fat Diet Mice (120.5)

MyD88-dependent Interplay Between Myeloid and Endothelial Cells in the Initiation and Progression of Obesity-Associated Inflammatory Diseases.

Lymphotoxin Regulates Commensal Responses to Enable Diet-Induced Obesity

Lymphotoxin Reduces Commensal Diversity to Enable Diet Induced Obesity (120.2)

Epithelial-specific Blockade of MyD88-dependent Pathway Causes Spontaneous Small Intestinal Inflammation.

High-fat-diet-induced gut microbiome changes in mice

IL-17A-dependent Gut Microbiota is Essential for Regulating Diet-Induced Disorders in Mice

Gut microbiota-bile acids-glucagon like peptide-1 axis contributes the resistance to high fat diet-induced obesity in mice

Targeted deletion of MyD88 in intestinal epithelial cells results in compromised antibacterial immunity associated with downregulation of polymeric immunoglobulin receptor, mucin-2, and antibacterial peptides

Regulated Inflammation and Lipid Metabolism in Colon Mrna Expressions of Obese Germfree Mice Responding to Enterobacter Cloacae B29 Combined with the High Fat Diet

Resistance to Diet Induced Visceral Fat Accumulation in C57BL/6NTac Mice Is Associated with an Enriched Lactococcus in the Gut Microbiota and the Phenotype of Immune B Cells in Intestine and Adipose Tissue

Intestine Specific Over‐expression of DGAT1 in Mice Alters Triacylglycerol Storage in Enterocytes, but Not Body Weight in Response to a High Fat Diet

The Role of Gut Microbiota in the Resistance to Obesity in Mice Fed a High Fat Diet

Intestine Specific Expression of DGAT1 Reverses the Resistance to Diet‐induced Obesity Phenotype of DGAT1‐deficient Female Mice

Tu1206 EFFECT OF BACILLUS SUBTILIS AND ENTEROCOCCUS FAECALIS SUPERNATANT ON SERT EXPRESSION IN ENTEROCYTES AND RAT INTESTINAL TISSUES

Gut microbiota affects obesity susceptibility in mice through gut metabolites

Obesity Modulates Intestinal Intraepithelial T Cell Persistence, CD103 and CCR9 Expression, and Outcome in Dextran Sulfate Sodium-Induced Colitis

Distinct Gut Microbiota and Arachidonic Acid Metabolism in Obesity-Prone and Obesity-Resistant Mice with a High-Fat Diet

Blocking MyD88 signaling with MyD88 inhibitor prevents colitis-associated colorectal cancer development by maintaining colonic microbiota homeostasis

Deficiency of intestinal Bmal1 prevents obesity induced by high-fat feeding

Gut Microbiota Dysbiosis Ameliorates in LNK-Deficient Mouse Models with Obesity-Induced Insulin Resistance Improvement